BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Diallyl Trisulfide

diallyl trisulfide [Supplementary Concept] major component of garlic; inhibits platelet aggregation but not prostacyclin

246+ PubMed studies analyzed · Evidence Score: 36.8

Research Domains

Diallyl Trisulfide has been studied across 19 research domains including 🔬 Oncology, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 62% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Diallyl Trisulfide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Camphor
3 shared targets
Estramustine
4 shared targets
acrolein
2 shared targets
iodoform
3 shared targets
Sulfinpyrazone
3 shared targets
tyrphostin
2 shared targets
Iodoacetamide
5 shared targets
juglone
5 shared targets
Semustine
2 shared targets
DEET
2 shared targets
Loading evidence profile...

This evidence profile for Diallyl Trisulfide is generated deterministically from 246 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.